Progyny (PGNY) News Today $14.09 +0.11 (+0.79%) (As of 10:02 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Landscape Capital Management L.L.C. Acquires 93,374 Shares of Progyny, Inc. (NASDAQ:PGNY)Landscape Capital Management L.L.C. raised its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 126.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 167,157 shares of the company's stock after buying an additional 93,374 shares dNovember 21 at 7:25 AM | marketbeat.com76,350 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Aurora Investment CounselAurora Investment Counsel acquired a new position in Progyny, Inc. (NASDAQ:PGNY - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 76,350 shares of the company's stock, valued at approximately $1,280,000. AurNovember 21 at 7:01 AM | marketbeat.comHere’s Why Progyny (PGNY) Was Under Pressure in Q3November 18 at 8:35 PM | insidermonkey.comJohnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) ShareholdersNovember 18 at 11:25 AM | globenewswire.comBrokerages Set Progyny, Inc. (NASDAQ:PGNY) Price Target at $25.42November 18 at 2:27 AM | americanbankingnews.comProgyny: After A Terrible Year, I'm Out (Rating Downgrade)November 18 at 12:01 AM | seekingalpha.comTruist Financial Reaffirms "Hold" Rating for Progyny (NASDAQ:PGNY)November 17, 2024 | americanbankingnews.comProgyny (NASDAQ:PGNY) Sets New 52-Week Low on Analyst DowngradeNovember 16, 2024 | americanbankingnews.comProgyny (NASDAQ:PGNY) Hits New 1-Year Low Following Analyst DowngradeProgyny (NASDAQ:PGNY) Reaches New 1-Year Low After Analyst DowngradeNovember 15, 2024 | marketbeat.comEntropy Technologies LP Makes New $761,000 Investment in Progyny, Inc. (NASDAQ:PGNY)Entropy Technologies LP bought a new position in Progyny, Inc. (NASDAQ:PGNY - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 45,384 shares of the company's stock, valued at approximately $761,000. Entropy TechnologiesNovember 15, 2024 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Hold" by BrokeragesProgyny, Inc. (NASDAQ:PGNY - Get Free Report) has earned a consensus recommendation of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have given a buy ratingNovember 15, 2024 | marketbeat.comProgyny (NASDAQ:PGNY) Shares Gap Down Following Weak EarningsNovember 15, 2024 | americanbankingnews.comProgyny Faces Challenges with Lowered Expectations Amid New InitiativesNovember 14, 2024 | markets.businessinsider.comTruist Securities Downgrades Progyny (PGNY)November 14, 2024 | msn.comProgyny price target lowered to $17 from $30 at BarclaysNovember 14, 2024 | markets.businessinsider.comBarclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00Barclays reduced their price objective on shares of Progyny from $30.00 to $17.00 and set an "overweight" rating for the company in a research note on Thursday.November 14, 2024 | marketbeat.comProgyny, Inc. to Present at Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comGSA Capital Partners LLP Invests $1.48 Million in Progyny, Inc. (NASDAQ:PGNY)GSA Capital Partners LLP purchased a new stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 88,527 shares of the company's stock, valued at approximately $1,484,000. GSA Capital ParNovember 14, 2024 | marketbeat.comProgyny price target lowered to $21 from $22 at BofANovember 14, 2024 | markets.businessinsider.comBarclays Issues a Buy Rating on Progyny (PGNY)November 13, 2024 | markets.businessinsider.comProgyny, Inc. (NASDAQ:PGNY) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comProgyny stock plunges 18% amid lowered guidance, Truist downgradeNovember 13, 2024 | msn.comWhy Progyny Stock Crashed TodayNovember 13, 2024 | fool.comProgyny (NASDAQ:PGNY) Shares Gap Down After Earnings MissProgyny (NASDAQ:PGNY) Shares Gap Down on Disappointing EarningsNovember 13, 2024 | marketbeat.comCanaccord Genuity Group Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00Canaccord Genuity Group decreased their target price on shares of Progyny from $18.00 to $17.00 and set a "hold" rating for the company in a research report on Wednesday.November 13, 2024 | marketbeat.comProgyny (NASDAQ:PGNY) Releases Earnings Results, Misses Expectations By $0.26 EPSProgyny (NASDAQ:PGNY - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Progyny had a return on equity of 11.97% and a net margin of 5.54%. The business had revenue of $286.63 million during the quarter, compared to analyst estimates of $296.85 million. During the same quarter last year, the firm posted $0.16 EPS. The company's revenue was up 2.0% compared to the same quarter last year.November 13, 2024 | marketbeat.comProgyny's (PGNY) "Hold" Rating Reiterated at Truist FinancialTruist Financial reaffirmed a "hold" rating and set a $19.00 price objective (down from $26.00) on shares of Progyny in a research note on Wednesday.November 13, 2024 | marketbeat.comProgyny, Inc. Reports Steady Growth Amid Strategic WinsNovember 13, 2024 | markets.businessinsider.comProgyny (PGNY) Receives a Hold from JMP SecuritiesNovember 13, 2024 | markets.businessinsider.comProgyny Inc (PGNY) Q3 2024 Earnings Call Highlights: Strong Client Growth Amid Utilization ...November 13, 2024 | finance.yahoo.comProgyny reports Q3 adjusted EPS 40c, consensus 13cNovember 13, 2024 | markets.businessinsider.comProgyny, Inc. (PGNY) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comProgyny, Inc. Announces Third Quarter 2024 ResultsNovember 12, 2024 | globenewswire.comProgyny Inc (PGNY) Q3 2024 Earnings Report Preview: What to Look ForNovember 12, 2024 | finance.yahoo.comProgyny (NASDAQ:PGNY) Might Be Having Difficulty Using Its Capital EffectivelyNovember 9, 2024 | finance.yahoo.comProgyny (PGNY) Client Retention Narrative Under Examination - Hagens BermanNovember 8, 2024 | globenewswire.comJohnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) ShareholdersNovember 8, 2024 | globenewswire.comProgyny, Inc. (NASDAQ:PGNY) Shares Acquired by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS raised its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 15.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 976,501 shares of the company's stock after purchasing an additional 132,672 shares durNovember 7, 2024 | marketbeat.comState of Alaska Department of Revenue Has $751,000 Stake in Progyny, Inc. (NASDAQ:PGNY)State of Alaska Department of Revenue grew its stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 397.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,819 shares of the company's stocNovember 7, 2024 | marketbeat.comProgyny (PGNY) Scheduled to Post Earnings on TuesdayProgyny (NASDAQ:PGNY) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641765)November 5, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNYNovember 2, 2024 | prnewswire.comProgyny (PGNY) Earnings Dates & ReportsNovember 1, 2024 | investing.comProgyny, Inc. Announces Details for Its Third Quarter 2024 Results ReportOctober 29, 2024 | globenewswire.comInternational Assets Investment Management LLC Raises Stock Holdings in Progyny, Inc. (NASDAQ:PGNY)International Assets Investment Management LLC raised its position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 1,576.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,565,118 shares of the company's stockOctober 28, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNYOctober 25, 2024 | prnewswire.comJefferies healthcare analyst holds an analyst/industry conference callOctober 25, 2024 | markets.businessinsider.comProgyny (PGNY) Client Retention Narrative Under Examination - Hagens BermanOctober 21, 2024 | globenewswire.comProgyny, Inc. (NASDAQ:PGNY) Receives Consensus Recommendation of "Hold" from BrokeragesProgyny, Inc. (NASDAQ:PGNY - Get Free Report) has earned a consensus rating of "Hold" from the twelve research firms that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The aveOctober 21, 2024 | marketbeat.comProgyny's (NASDAQ:PGNY) earnings have declined over three years, contributing to shareholders 73% lossOctober 20, 2024 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNYOctober 17, 2024 | prnewswire.com Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] PGNY Media Mentions By Week PGNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGNY News Sentiment▼-0.050.46▲Average Medical News Sentiment PGNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGNY Articles This Week▼126▲PGNY Articles Average Week Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sotera Health News agilon health News Viemed Healthcare News Global Cord Blood News Marpai News BioRestorative Therapies News Ontrak News Mangoceuticals News NewGenIvf Group News Global Cord Blood News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGNY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.